1v3x: Difference between revisions
New page: left|200px<br /> <applet load="1v3x" size="450" color="white" frame="true" align="right" spinBox="true" caption="1v3x, resolution 2.20Å" /> '''Factor Xa in comple... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1v3x. | [[Image:1v3x.jpg|left|200px]]<br /><applet load="1v3x" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1v3x" size=" | |||
caption="1v3x, resolution 2.20Å" /> | caption="1v3x, resolution 2.20Å" /> | ||
'''Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine'''<br /> | '''Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine'''<br /> | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1V3X is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with CA and D76 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] Full crystallographic information is available from [http:// | 1V3X is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=CA:'>CA</scene> and <scene name='pdbligand=D76:'>D76</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1V3X OCA]. | ||
==Reference== | ==Reference== | ||
| Line 29: | Line 28: | ||
[[Category: serine protease]] | [[Category: serine protease]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:04:14 2008'' | ||
Revision as of 18:04, 15 February 2008
|
Factor Xa in complex with the inhibitor 1-[6-methyl-4,5,6,7-tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2-carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine
OverviewOverview
Our exploratory study was based on the concept that a non-amidine factor, Xa (fXa) inhibitor is suitable for an orally available anticoagulant. We, synthesized and evaluated a series of, N-(6-chloronaphthalen-2-yl)sulfonylpiperazine derivatives incorporating, various fused-bicyclic rings containing an aliphatic amine expected to be, S4 binding element. Among this series, 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine type 61 displayed, orally potent anti-fXa activity and evident prolongation of prothrombin, time (PT) with the moderate bioavailability in rats. The X-ray crystal, analysis afforded an obvious binding mode that, 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine and 6-chloronaphthalene, respectively bound to S4 and S1 subsites. In this X-ray study, we, discovered a novel intramolecular S-O close contact. Ab initio energy, calculations of model compounds deduced that conformers with the most, close S-O proximity were most stable. The Mulliken population analysis, proposed that this energy profile was caused by both of electrostatic S-O, affinity and N-O repulsion. The results of these calculations and X-ray, analysis suggested a possibility that the restricted conformation effected, the affinity to S4 subsite of fXa.
DiseaseDisease
Known disease associated with this structure: Factor X deficiency OMIM:[227600]
About this StructureAbout this Structure
1V3X is a Protein complex structure of sequences from Homo sapiens with and as ligands. Active as Coagulation factor Xa, with EC number 3.4.21.6 Full crystallographic information is available from OCA.
ReferenceReference
Synthesis and conformational analysis of a non-amidine factor Xa inhibitor that incorporates 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine as S4 binding element., Haginoya N, Kobayashi S, Komoriya S, Yoshino T, Suzuki M, Shimada T, Watanabe K, Hirokawa Y, Furugori T, Nagahara T, J Med Chem. 2004 Oct 7;47(21):5167-82. PMID:15456260
Page seeded by OCA on Fri Feb 15 17:04:14 2008